Nanosuspension for Improving Dissolution of Poorly Soluble Drug: Development and In Vitro Characterization
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: JIVANI, Rishad (Dr. Subhash Technical campus, Faculty of Pharmacy, Pharmaceutical Technology, Junagadh, India)
- Co-author(s): Rishad jivani: Pharmaceutical Technology, Dr. Subhash Technical campus, Faculty of Pharmacy, Junagadh, India
Moin Soniwala: Pharmaceutical Technology, B. K. Modi Government Pharmacy college , RAJKOT, India
More than 40% of new chemical entities developed in pharmaceutical industry are poorly insoluble, these leads to slow drug absorption and eventually leads to poor bioavailability.
The objective of the present research was to develop a nanosuspension formulation of poorly water soluble drug Risperidone and to evaluate the influence.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.